References
- Fleming , Ra , Miller , Aa and Stewart , Cf. 1989 . Etoposide: an update. . Clin Pharm. , 3 : 274
- Bennett , Cl , Sinkule , Ja , Schilsky , Rl , Senekjian , E. and Choi , Ke . 1987 . Phase I clinical and pharmacological study of etoposide in patients with advanced cancer. . Cancer Res. , 47 : 1952
- Miller , Aa , Stewart , Cf. and Tolley , Ea. 1990 . Clinical pharmacodynamics of continuous infusion etoposide. . Cancer Chemother Pharmacol. , 25 : 361
- Stewart , Cf , Arbuck , Sg , Fleming , Ra and Evans , We. 1990 . Relation of systemic exposure to unbound etoposide and hematological toxicity in adult cancer patients. . J Clin Oncol , Submitted to
- Ratain , Mf , Schilsky , Rl , Choi , E. , Guarnieri , C. , Grimmer , D. , Vogelzang , Nj , Senekjian , E. and Liebner , Ma. 1984 . Adaptive control of etoposide dosing: Impact of interpatient pharmacodynamic variability. . Clin Pharmacol Ther. , 45 : 226
- Allen , Lm. 1980 . Analysis of 4′-demethylepi-podophyllotoxin-9-(4,6-O- ethylidene-β-D-glucopyranoside) by high-pressure liquid chromatography. . J Pharm Sci. , 69 : 1460
- Hersh , Mr and Ludden , Tm. 1986 . High-performance liquid chromatographic assay for etoposide in human plasma. . J Pharm Sci. , 75 : 815
- Farina , P. , Marzillo , G. and D'incalci , M. 1981 . High-performance liquid chromatography determination of 4′-demethylepipodophyllotoxin-9-(4,6-O-ethylidene β-D-glucopyranoside) (VP-16–213) in human plasma. . J Chromatogr. , 222 : 141
- Strife , Rj , Jardine , I. and Colvin , M. 1981 . Analysis of the anticancer drugs etoposide (VP16–213) and teniposide (VM26) by high-performance liquid chromatography with fluoresence detection. . J Chromatogr. , 224 : 168
- Sinkule , Ja and Evans , We. 1984 . High-performance liquid chromatographic analysis of the semisynthetic epipodophyllotoxins teniposide and etoposide using electrochemical detection. . J Pharm Sci , 72 : 164